NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.77
+0.0300 (+1.09%)
At Close: May 20, 2024
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
09:00am, Friday, 10'th Sep 2021
CANTON, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Forget Bargains, Play 5 Stocks with Rising P/E Instead
05:30pm, Thursday, 02'nd Sep 2021
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Net Health Partners with Organogenesis for More Efficient Insurance Benefits Verification
07:00am, Monday, 23'rd Aug 2021
PITTSBURGH, Aug. 23, 2021 /PRNewswire/ -- Net Health, a leading provider of cloud-based software for specialty medical providers, announced today that Organogenesis Holdings Inc. (Nasdaq: ORGO), has
Organogenesis Q2 Earnings Beat Expectations; Sales Jump 79%; Raises FY21 Sales Outlook
05:31pm, Tuesday, 10'th Aug 2021
Organogenesis Holdings Inc (NASDAQ: ORGO) Q2 revenues increased 79% Y/Y to $123.2 million, edging out analysts' average expectation of $107.30 million. The increase was driven by a $51.7 million inc
ORGO Stock Price Increases Over 15% Pre-Market: Why It Happened
09:09am, Tuesday, 10'th Aug 2021
The stock price of Organogenesis Holdings Inc (NASDAQ: ORGO) increased by over 15% pre-market. This is why it happened.
Organogenesis Holdings' (ORGO) CEO Gary Gillheeney on Q2 2021 Results - Earnings Call Transcript
11:16pm, Monday, 09'th Aug 2021
Organogenesis Holdings' (ORGO) CEO Gary Gillheeney on Q2 2021 Results - Earnings Call Transcript
Organogenesis (ORGO) Q2 Earnings and Revenues Beat Estimates
06:28pm, Monday, 09'th Aug 2021
Organogenesis (ORGO) delivered earnings and revenue surprises of 114.29% and 16.61%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Organogenesis Holdings: Q2 Earnings Insights
04:39pm, Monday, 09'th Aug 2021
Shares of Organogenesis Holdings (NASDAQ:ORGO) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year over year to $0.15, which
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021
07:30am, Friday, 02'nd Jul 2021
CANTON, Mass., July 02, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness
11:17am, Monday, 21'st Jun 2021
4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness
Why Organogenesis Holdings Blasted 7.7% Higher Today
05:57pm, Thursday, 27'th May 2021
The company will be a component of a high-profile stock index.
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2021 Results - Earnings Call Transcript
05:03pm, Tuesday, 11'th May 2021
Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q1 2021 Results - Earnings Call Transcript
Organogenesis (ORGO) Surpasses Q1 Earnings and Revenue Estimates
06:47pm, Monday, 10'th May 2021
Organogenesis (ORGO) delivered earnings and revenue surprises of 275.00% and 18.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CORRECTING and REPLACING – Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results
05:13pm, Monday, 10'th May 2021
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Organogenesis Holdings Inc. (Nasdaq: ORGO), please note that in the third bullet of the F
Organogenesis Holdings: Q1 Earnings Insights
05:09pm, Monday, 10'th May 2021
Shares of Organogenesis Holdings (NASDAQ:ORGO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 143.75% year over year to $0.07, which
